Symbiox Investment & Trading Co Ltd (SYMBIOX.BO)
INR 4.25
(-1.39%)
INR 4.25
(-1.39%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.48 Million | -44.72 Million | -3.51 Million | 11.35 Million | 2.69 Million | 14.27 Million |
| Net Income | 2.47 Million | 2.15 Million | 1.87 Million | 937.75 Thousand | 316.87 Thousand | -89.71 Thousand |
| Depreciation & Amortization | 20 Thousand | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -32.41 Million | -46.36 Million | -5.14 Million | 10.68 Million | 2.6 Million | 14.86 Million |
| Other non-cash items | -10.77 Million | -510.38 Thousand | -243.81 Thousand | -264.76 Thousand | -227.4 Thousand | -504.15 Thousand |
| Investing Cash Flow | 28.27 Million | 48.22 Million | 3.95 Million | -9.96 Million | -3.84 Million | -15.49 Million |
| Investments in PPE | -164 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 28.43 Million | 48.22 Million | 3.95 Million | -9.96 Million | -3.84 Million | -15.49 Million |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 7.81 Million | 701.8 Thousand | -8.67 Million | -3000.00 | 12.61 Million | 3.4 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 1.18 Million | -2.08 Million | - | - | - | 98.17 Thousand |
| Other working capital | -30.81 Million | -44.99 Million | 3.52 Million | 10.68 Million | -10 Million | 11.36 Million |
| Cash at beginning of period | 5.42 Million | 1.92 Million | 1.47 Million | 89.38 Thousand | 1.23 Million | 2.45 Million |
| Cash at end of period | 3.2 Million | 5.42 Million | 1.92 Million | 1.47 Million | 89.38 Thousand | 1.23 Million |
| Capital Expenditure | -164 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.21 Million | 3.49 Million | 444.05 Thousand | 1.39 Million | -1.14 Million | -1.22 Million |
| Free Cash Flow | -30.65 Million | -44.72 Million | -3.51 Million | 11.35 Million | 2.69 Million | 14.27 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 56 Thousand | -274.48 Thousand | 2.47 Million | -90 Thousand | 2.23 Million | 1.13 Million |
| Depreciation & Amortization | - | - | 20 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -32.41 Million | - | - | - |
| Other non-cash items | -56 Thousand | 274.48 Thousand | -10.77 Million | 90 Thousand | -2.23 Million | -1.13 Million |
| Investing Cash Flow | - | - | 28.27 Million | - | - | - |
| Investments in PPE | - | - | -164 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 28.43 Million | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | 7.81 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 1.18 Million | - | - | - |
| Other working capital | - | - | -30.81 Million | - | - | - |
| Cash at beginning of period | - | - | 5.42 Million | - | - | - |
| Cash at end of period | - | - | 3.2 Million | - | - | - |
| Capital Expenditure | - | - | -164 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -2.21 Million | - | - | - |
| Free Cash Flow | - | - | -30.65 Million | - | - | - |
ACME
SREEL
2440
FED
BOOZT-DKK
RICY